Can-Fite BioPharma Files Form 6-K
Ticker: CANF · Form: 6-K · Filed: Aug 30, 2024 · CIK: 1536196
| Field | Detail |
|---|---|
| Company | Can-Fite Biopharma LTD. (CANF) |
| Form Type | 6-K |
| Filed Date | Aug 30, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $9.0 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: CANF
TL;DR
Can-Fite BioPharma filed a routine 6-K update with the SEC.
AI Summary
On August 30, 2024, Can-Fite BioPharma Ltd. filed a Form 6-K, incorporating this report into its existing registration statements on Form S-8 and Form F-3. The filing pertains to its status as a foreign private issuer for the month of August 2024.
Why It Matters
This filing updates the SEC on Can-Fite BioPharma's status as a foreign private issuer, which is a routine regulatory requirement for companies listed in the US but incorporated elsewhere.
Risk Assessment
Risk Level: low — This is a standard regulatory filing and does not appear to contain new material financial or operational information.
Key Players & Entities
- Can-Fite BioPharma Ltd. (company) — Registrant
- August 30, 2024 (date) — Filing Date
- Form 6-K (document) — Filing Type
- Form S-8 (document) — Incorporated Registration Statement
- Form F-3 (document) — Incorporated Registration Statement
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information to the SEC that the company has made or is required to make public in its home country.
What is Can-Fite BioPharma Ltd.'s principal executive office address?
Can-Fite BioPharma Ltd.'s principal executive offices are located at 26 Ben Gurion Street, Ramat Gan, 5257346, Israel.
Under which form does Can-Fite BioPharma Ltd. typically file annual reports?
Can-Fite BioPharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the Commission File Number for Can-Fite BioPharma Ltd.?
The Commission File Number for Can-Fite BioPharma Ltd. is 001-36203.
What is the SIC code for Can-Fite BioPharma Ltd.?
The Standard Industrial Classification (SIC) code for Can-Fite BioPharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 827 words · 3 min read · ~3 pages · Grade level 12.3 · Accepted 2024-08-30 16:18:30
Key Financial Figures
- $9.0 million — ng an aggregate offering price of up to $9.0 million (the “ADSs”). The offer an
Filing Documents
- ea0212642-6k_canfite.htm (6-K) — 16KB
- ea021264201ex5-1_canfite.htm (EX-5.1) — 31KB
- ea021264201ex10-1_canfite.htm (EX-10.1) — 238KB
- ex5-1_001.jpg (GRAPHIC) — 6KB
- 0001213900-24-074547.txt ( ) — 295KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 30, 2024 By: /s/ Motti Farbstein Motti Farbstein Chief Executive Officer and Chief Financial Officer 2